echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Eddie Pharmaceuticals and PerkinElmer reached a strategic cooperation

    Eddie Pharmaceuticals and PerkinElmer reached a strategic cooperation

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>



    In the first year of listing, join hands to develop new cooperation in the field of AIDS diagnosis and treatment

    As far as the deployment of both parties in the field of HIV diagnosis and treatment is concerned, 2021 is a crucial "first year of listing"


    As a cutting-edge innovative drug R&D company, Aidi Pharmaceuticals is focusing on drug R&D and commercialization in the HIV field


    PerkinElmer is a world-renowned technology company with decades of accumulation in infection diagnosis and other fields


    Join forces to implement the strategy of "integration of AIDS diagnosis and treatment"

    According to the latest data released by the National Health Commission, as of the end of October 2021, 1.


    Starting from the strategy of “meeting the urgent needs of domestic AIDS treatment”, Aidi Pharmaceuticals is committed to practicing the concept of “integration of HIV diagnosis and treatment” by building a Chinese->


    Taking this strategic cooperation signing as a starting point, the two parties will carry out a series of multi-dimensional business cooperation for the Chinese market in the future, including marketing, clinical research cooperation, and charity activities cooperation



    About Addison Pharmaceutical

    Jiangsu Aidi Pharmaceutical Co.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.